Cancer Investigation, Volume 24, Issue 7 (2006)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Cancer Investigation, Volume 24, Issue 7 (2006)

See all volumes and issues
Vol 42, 2024 Vol 41, 2023 Vol 40, 2022 Vol 39, 2021 Vol 38, 2020 Vol 37, 2019 Vol 36, 2018 Vol 35, 2017 Vol 34, 2016 Vol 33, 2015 Vol 32, 2014 Vol 31, 2013 Vol 30, 2012 Vol 29, 2011 Vol 28, 2010 Vol 27, 2009 Vol 28, 2010 Vol 27, 2009 Vol 26, 2008 Vol 25, 2007 Volume 24, 2006 Vol 23, 2005 Vol 22, 2004 Vol 21, 2003 Vol 20, 2002 Vol 19, 2001 Vol 18, 2000 Vol 17, 1999 Vol 16, 1998 Vol 15, 1997 Vol 14, 1996 Vol 13, 1995 Vol 12, 1994 Vol 11, 1993 Vol 10, 1992 Vol 9, 1991 Vol 8, 1990 Vol 7, 1989 Vol 6, 1988 Vol 5, 1987 Vol 4, 1986 Vol 3, 1985 Vol 2, 1984 Vol 1, 1983
Download citations Download PDFs Download issue

ORIGINAL ARTICLE

Article
Chemoprotection Effect of Multidrug Resistance 1 (MDR1) Gene Transfer to Hematopoietic Progenitor Cells and Engrafted in Mice with Cancer Allows Intensified Chemotherapy
Chunbao Guo M.D., Ph.D. & Xianqing Jin M.D., Ph.D.
Pages: 659-668
Published online: 11 Jun 2009
AbstractforChemoprotection Effect of Multidrug Resistance 1 (MDR1) Gene Transfer to Hematopoietic Progenitor Cells and Engrafted in Mice with Cancer Allows Intensified Chemotherapy | Full Text | References | PDF (2.2 MB)
  • 87 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Response to Neoadjuvant Chemotherapy in Breast Cancer Could be Predictable by Measuring a Novel Serum Apoptosis Product, Caspase-Cleaved Cytokeratin 18: A Prospective Pilot Study
Mutlu Demiray M.D., Engin Engin Ulukaya M.D., Ph.D., Murat Arslan M.D., Sehsuvar Gokgoz M.D., Ozlem Saraydaroglu M.D., Ilker Ercan Ph.D., Turkkan Evrensel M.D. & Osman Manavoglu M.D.
Pages: 669-676
Published online: 11 Jun 2009
AbstractforResponse to Neoadjuvant Chemotherapy in Breast Cancer Could be Predictable by Measuring a Novel Serum Apoptosis Product, Caspase-Cleaved Cytokeratin 18: A Prospective Pilot Study | Full Text | References | PDF (383.7 KB)
  • 148 Views
  • 52 CrossRef citations
  • 0Altmetric
Article
A Pilot Phase II Trial of Valspodar Modulation of Multidrug Resistance to Paclitaxel in the Treatment of Metastatic Carcinoma of the Breast (E1195): A Trial of the Eastern Cooperative Oncology Group
Robert W. Carlson M.D., Anne M. O'Neill M.S., Lori J. Goldstein M.D., Branimir I. Sikic M.D., Neil Abramson M.D., James A. Stewart M.D., Nancy E. Davidson M.D. & William C. Wood M.D.
Pages: 677-681
Published online: 11 Jun 2009
AbstractforA Pilot Phase II Trial of Valspodar Modulation of Multidrug Resistance to Paclitaxel in the Treatment of Metastatic Carcinoma of the Breast (E1195): A Trial of the Eastern Cooperative Oncology Group | Full Text | References | PDF (110.2 KB)
  • 66 Views
  • 21 CrossRef citations
  • 0Altmetric
Article
Is There Any Association Between Nek3 and Cancers with Frequent 13q14 Deletion?
M. Hernández Ph.D. & T. A. Almeida Ph.D.
Pages: 682-688
Published online: 11 Jun 2009
AbstractforIs There Any Association Between Nek3 and Cancers with Frequent 13q14 Deletion? | Full Text | References | PDF (2.3 MB)
  • 121 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
p53 Gene Mutations in Sporadic Colorectal Carcinoma in Guangxi Region
Feng Gao M.D., Chensheng Li M.D., Wei Li M.D., Lisheng Chen M.D., Zongjiang Tang M.S. & Weizhong Tang M.D.
Pages: 689-695
Published online: 11 Jun 2009
Abstractforp53 Gene Mutations in Sporadic Colorectal Carcinoma in Guangxi Region | Full Text | References | PDF (2.9 MB)
  • 88 Views
  • 1 CrossRef citations
  • 0Altmetric

REVIEW

Review Article
Current Update of Cytokines in Pancreatic Cancer: Pathogenic Mechanisms, Clinical Indication, and Therapeutic Values
Louis W. Feurino B.A., William E. Fisher M.D., Uddalak Bharadwaj Ph.D., Qizhi Yao M.D., Ph.D., Changyi Chen M.D., Ph.D. & Min Li Ph.D.
Pages: 696-703
Published online: 11 Jun 2009
AbstractforCurrent Update of Cytokines in Pancreatic Cancer: Pathogenic Mechanisms, Clinical Indication, and Therapeutic Values | Full Text | References | PDF (89.5 KB)
  • 191 Views
  • 21 CrossRef citations
  • 0Altmetric
Review Article
A Systematic Review on Drug Interactions in Oncology
Rachel P. Riechelmann M.D. & Everardo D. Saad M.D.
Pages: 704-712
Published online: 11 Jun 2009
AbstractforA Systematic Review on Drug Interactions in Oncology | Full Text | References | PDF (93.4 KB)
  • 579 Views
  • 40 CrossRef citations
  • 0Altmetric

OP-ED

Article
Could BEACOPP Be the New Standard for the Treatment of Advanced Hodgkin's Lymphoma (HL)?
V. Diehl M.D. & K. Behringer M.D.
Pages: 713-717
Published online: 11 Jun 2009
AbstractforCould BEACOPP Be the New Standard for the Treatment of Advanced Hodgkin's Lymphoma (HL)? | Full Text | References | PDF (1 MB)
  • 74 Views
  • 19 CrossRef citations
  • 0Altmetric

NEW DRUGS

Article
Alemtuzumab in CLL and Other Lymphoid Neoplasms
Farhad Ravandi M.D. & Susan O'Brien M.D.
Pages: 718-725
Published online: 11 Jun 2009
AbstractforAlemtuzumab in CLL and Other Lymphoid Neoplasms | Full Text | References | PDF (87.6 KB)
  • 164 Views
  • 26 CrossRef citations
  • 0Altmetric

Explore articles